Screener
Relay Therapeutics, Inc. RLAY Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206454
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Proceeds from issuance of common stock via at-the-market offerings, net | 137,090 | — |
| Proceeds from issuance of common stock through exercise of stock options | 1,692 | — |
| Net cash provided by financing activities | 138,782 | — |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 120,571 | (30,745) |
| Cash, cash equivalents, and restricted cash at beginning of period | 85,354 | 126,406 |
| Cash, cash equivalents, and restricted cash at end of period | $205,925 | $95,661 |
| Supplemental disclosure of non-cash activities: | ||
| Periodic change in additions of property and equipment within current liabilities | — | $61 |
Item 1. Financial Statements.
FAQ
- What is Relay Therapeutics, Inc.'s net change in cash?
- Relay Therapeutics, Inc. (RLAY) reported net change in cash of $120.57M in Q1 2026.
- How has Relay Therapeutics, Inc.'s net change in cash changed year-over-year?
- Relay Therapeutics, Inc.'s net change in cash increased by 492.2% year-over-year, from -$30.75M to $120.57M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Relay Therapeutics, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude